UroGen Pharma
URGN
#6746
Rank
ยฃ0.37 B
Marketcap
ยฃ8.85
Share price
-5.65%
Change (1 day)
-11.49%
Change (1 year)

Revenue for UroGen Pharma (URGN)

Revenue in 2024 (TTM): ยฃ67.7 Million

According to UroGen Pharma's latest financial reports the company's current revenue (TTM ) is ยฃ67.25 Million. In 2023 the company made a revenue of ยฃ64.92 Million an increase over the revenue in the year 2022 that were of ยฃ53.19 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for UroGen Pharma from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ67.7 M4.29%
2023 ยฃ64.92 M22.05%
2022 ยฃ53.19 M49.47%
2021 ยฃ35.59 M311.16%
2020 ยฃ8.65 M62960.72%
2019 ยฃ0.01 M-98.46%
2018 ยฃ0.88 M-85.28%
2017 ยฃ6.03 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA